JP4098796B2 - マウス腸骨リンパ節を用いたモノクローナル抗体の作製 - Google Patents
マウス腸骨リンパ節を用いたモノクローナル抗体の作製 Download PDFInfo
- Publication number
- JP4098796B2 JP4098796B2 JP2005233741A JP2005233741A JP4098796B2 JP 4098796 B2 JP4098796 B2 JP 4098796B2 JP 2005233741 A JP2005233741 A JP 2005233741A JP 2005233741 A JP2005233741 A JP 2005233741A JP 4098796 B2 JP4098796 B2 JP 4098796B2
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- lymph nodes
- mouse
- iliac lymph
- fusion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000001165 lymph node Anatomy 0.000 title claims description 27
- 238000004519 manufacturing process Methods 0.000 title claims description 7
- 239000000427 antigen Substances 0.000 claims description 31
- 102000036639 antigens Human genes 0.000 claims description 31
- 108091007433 antigens Proteins 0.000 claims description 31
- 238000000034 method Methods 0.000 description 31
- 210000004027 cell Anatomy 0.000 description 25
- 238000002649 immunization Methods 0.000 description 20
- 230000003053 immunization Effects 0.000 description 20
- 238000002347 injection Methods 0.000 description 18
- 239000007924 injection Substances 0.000 description 18
- 230000007910 cell fusion Effects 0.000 description 16
- 230000004927 fusion Effects 0.000 description 14
- 210000000952 spleen Anatomy 0.000 description 14
- 241000699666 Mus <mouse, genus> Species 0.000 description 12
- 241000699670 Mus sp. Species 0.000 description 10
- 241000700159 Rattus Species 0.000 description 8
- 108010058846 Ovalbumin Proteins 0.000 description 7
- 229940092253 ovalbumin Drugs 0.000 description 7
- 238000002965 ELISA Methods 0.000 description 5
- 239000000839 emulsion Substances 0.000 description 5
- 108090000765 processed proteins & peptides Proteins 0.000 description 5
- 238000002835 absorbance Methods 0.000 description 4
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- 206010035226 Plasma cell myeloma Diseases 0.000 description 3
- 239000002671 adjuvant Substances 0.000 description 3
- 210000003719 b-lymphocyte Anatomy 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 229940126619 mouse monoclonal antibody Drugs 0.000 description 3
- 201000000050 myeloid neoplasm Diseases 0.000 description 3
- 210000004989 spleen cell Anatomy 0.000 description 3
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000012228 culture supernatant Substances 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- 108010078791 Carrier Proteins Proteins 0.000 description 1
- 208000008771 Lymphadenopathy Diseases 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241000237509 Patinopecten sp. Species 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 150000001413 amino acids Chemical group 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000005907 cancer growth Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000006058 immune tolerance Effects 0.000 description 1
- 230000016784 immunoglobulin production Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 235000020637 scallop Nutrition 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
Images
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Description
Cell Struct.Funct.20:151−156,1995
Cancer Metastasis Rev.18:421−425,1999
Claims (2)
- モノクローナル抗体の作製方法であって、
マウスの尾根部に抗原を投与する第1工程、および
腫大した腸骨リンパ節をマウスから取り出す第2工程
を包含し、
第2工程が、第1工程開始後30日以内に行われることを特徴とする作製方法。 - 第1工程が単回または複数回行われることを特徴とする請求項1に記載の作製方法。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005233741A JP4098796B2 (ja) | 2005-07-13 | 2005-07-13 | マウス腸骨リンパ節を用いたモノクローナル抗体の作製 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005233741A JP4098796B2 (ja) | 2005-07-13 | 2005-07-13 | マウス腸骨リンパ節を用いたモノクローナル抗体の作製 |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2007020547A JP2007020547A (ja) | 2007-02-01 |
JP2007020547A5 JP2007020547A5 (ja) | 2007-11-08 |
JP4098796B2 true JP4098796B2 (ja) | 2008-06-11 |
Family
ID=37782134
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2005233741A Active JP4098796B2 (ja) | 2005-07-13 | 2005-07-13 | マウス腸骨リンパ節を用いたモノクローナル抗体の作製 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4098796B2 (ja) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3252073A1 (en) | 2016-05-31 | 2017-12-06 | Sysmex Corporation | Monoclonal antibody reacting with glycopeptide, and use thereof |
WO2018181935A1 (ja) | 2017-03-30 | 2018-10-04 | シスメックス株式会社 | 抗ApoA1抗体 |
WO2022154121A1 (ja) | 2021-01-18 | 2022-07-21 | 富士フイルム和光純薬株式会社 | ヘプシジンの吸着抑制剤、吸着抑制方法、標準品、試薬、キットおよび測定方法 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021100715A1 (ja) * | 2019-11-18 | 2021-05-27 | 住友化学株式会社 | 抗体の作製方法 |
-
2005
- 2005-07-13 JP JP2005233741A patent/JP4098796B2/ja active Active
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3252073A1 (en) | 2016-05-31 | 2017-12-06 | Sysmex Corporation | Monoclonal antibody reacting with glycopeptide, and use thereof |
WO2018181935A1 (ja) | 2017-03-30 | 2018-10-04 | シスメックス株式会社 | 抗ApoA1抗体 |
WO2022154121A1 (ja) | 2021-01-18 | 2022-07-21 | 富士フイルム和光純薬株式会社 | ヘプシジンの吸着抑制剤、吸着抑制方法、標準品、試薬、キットおよび測定方法 |
Also Published As
Publication number | Publication date |
---|---|
JP2007020547A (ja) | 2007-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Harrison et al. | Research strategies to improve snakebite treatment: Challenges and progress | |
AU2016270640B2 (en) | Anti-CD40 antibodies and uses thereof | |
RU2486204C2 (ru) | Антитела против сd26 и способы их применения | |
ES2636239T3 (es) | Generación de moléculas de unión | |
KR20190117489A (ko) | 항-bcma 중쇄-단독 항체 | |
RU2010119450A (ru) | Антитело против bst2 | |
CN101827862A (zh) | 抗Aβ(20-42)球聚体的人源化抗体及其应用 | |
JP4098796B2 (ja) | マウス腸骨リンパ節を用いたモノクローナル抗体の作製 | |
TW201114436A (en) | Polypeptides and method of treatment | |
Murphy | VelocImmune: immunoglobulin variable region humanized mice | |
CN113271971A (zh) | 用于肝病的治疗的组合物和方法 | |
CN105770889A (zh) | 特异性结合脑源性神经营养因子前体蛋白的结合分子的应用 | |
WO2018157710A1 (zh) | Nav1.9的靶点多肽、与其结合的抗体及抗体片段和相关药物组合物 | |
WO2022248445A1 (en) | Animal models and therapeutic molecules | |
DE69735872T2 (de) | Menschliches adhäsionsmolekül occludin | |
CN102229651A (zh) | 一种治疗阿尔茨海默病的淀粉样蛋白膜内片段及其应用 | |
CN107446938A (zh) | 一种特异性靶向受体蛋白magea及其car‑t载体的构建方法 | |
US20210309726A1 (en) | Treatment of melanoma brain metastasis by inhibition of amyloid precursor protein cleavage | |
US20150174242A1 (en) | Monovalent anti-cd3 adjuvants | |
WO2023247779A1 (en) | Animal models and therapeutic molecules | |
JP2009284771A (ja) | 抗体産生細胞の作製方法 | |
WO2010014751A2 (en) | Monoclonal antibody zt/2f2 in targeted therapy of cancers overexpressing the ron receptor tyrosine kinase | |
Hao et al. | Development of a humanized anti-FABP4 monoclonal antibody for treatment of breast cancer | |
CN116783210A (zh) | Nkd2作为治疗肾纤维化的靶点 | |
CN117986356A (zh) | 一种制备抗体的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050908 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070828 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070828 |
|
RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7422 Effective date: 20070828 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20070828 |
|
A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20071029 |
|
A975 | Report on accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A971005 Effective date: 20071126 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20071211 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080205 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20080311 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20080313 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4098796 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110321 Year of fee payment: 3 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110321 Year of fee payment: 3 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110321 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120321 Year of fee payment: 4 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130321 Year of fee payment: 5 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130321 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140321 Year of fee payment: 6 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |